0
13
Journal Articles about Antipsychotics Showing 121-140 of 932
Brief Report | November 01, 2003
Olanzapine Effects on Auditory Sensory Gating in Schizophrenia
Celso Arango, M.D.; Ann Summerfelt, B.A.; Robert W. Buchanan, M.D.
The American Journal of Psychiatry. 2003 November ; 11(160):2066-2068
PDFPDF
Article | October 01, 2003
Effects of Typical, Atypical, and No Antipsychotic Drugs on Visual Contrast Detection in Schizophrenia
Yue Chen, Ph.D.; Deborah L. Levy, Ph.D.; Summer Sheremata, B.A.; Ken Nakayama, Ph.D.; Steven Matthysse, Ph.D.; Philip S. Holzman, Ph.D.
The American Journal of Psychiatry. 2003 October ; 10(160):1795-1801
PDFPDF
Article | October 01, 2003
Racial Disparity in the Use of Atypical Antipsychotic Medications Among Veterans
Laurel A. Copeland, M.P.H., Ph.D.; John E. Zeber, M.H.A.; Marcia Valenstein, M.D., M.S.; Frederic C. Blow, Ph.D.
The American Journal of Psychiatry. 2003 October ; 10(160):1817-1822
PDFPDF
Article | September 01, 2003
A Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Aripiprazole in Patients With Acute Bipolar Mania
Paul E. Keck, Jr., M.D.; Ronald Marcus, M.D.; Stavros Tourkodimitris, Ph.D.; Mirza Ali, Ph.D.; Amy Liebeskind, M.D.; Anutosh Saha, Ph.D.; Gary Ingenito, M.D.; Aripiprazole Study Group
The American Journal of Psychiatry. 2003 September ; 9(160):1651-1658
PDFPDF
Article | August 01, 2003
Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol
Jeffrey A. Lieberman, M.D.; Gary Tollefson, M.D., Ph.D.; Mauricio Tohen, M.D., Dr.P.H.; Alan I. Green, M.D.; Raquel E. Gur, M.D., Ph.D.; Rene Kahn, M.D., Ph.D.; Joseph McEvoy, M.D.; Diana Perkins, M.D., M.P.H.; Tonmoy Sharma, M.D.; Robert Zipursky, M.D.; Hank Wei, Ph.D.; Robert M. Hamer, Ph.D.; the HGDH Study Group
The American Journal of Psychiatry. 2003 August ; 8(160):1396-1404
PDFPDF
Article | August 01, 2003
Maintenance Treatment of Schizophrenia With Risperidone or Haloperidol: 2-Year Outcomes
Stephen R. Marder, M.D.; Shirley M. Glynn, Ph.D.; William C. Wirshing, M.D.; Donna A. Wirshing, M.D.; Doreen Ross; Clifford Widmark, M.D.; Jim Mintz, Ph.D.; Robert P. Liberman, M.D.; Karen E. Blair, M.S.
The American Journal of Psychiatry. 2003 August ; 8(160):1405-1412
PDFPDF
Article | August 01, 2003
Is Regionally Selective D2/D3 Dopamine Occupancy Sufficient for Atypical Antipsychotic Effect? An In Vivo Quantitative [123I]Epidepride SPET Study of Amisulpride-Treated Patients
Rodrigo A. Bressan, M.D., Ph.D.; Kjell Erlandsson, Ph.D.; Hugh M. Jones, M.R.C.Psych.; Rachel Mulligan, B.Sc., M.Sc., Ph.D.; Robert J. Flanagan, B.Sc., Ph.D., F.R.S.C., F.R.C.Path.; Peter J. Ell, M.D., Ph.D., F.R.C.P., M.R.C.R., F.Med.Sci.; Lyn S. Pilowsky, M.R.C.Psych., Ph.D.
The American Journal of Psychiatry. 2003 August ; 8(160):1413-1420
PDFPDF
Article | August 01, 2003
The Relationship of Clozapine and Haloperidol Treatment Response to Prefrontal, Hippocampal, and Caudate Brain Volumes
Celso Arango, M.D.; Alan Breier, M.D.; Robert McMahon, Ph.D.; William T. Carpenter, Jr., M.D.; Robert W. Buchanan, M.D.
The American Journal of Psychiatry. 2003 August ; 8(160):1421-1427
PDFPDF
Article | August 01, 2003
Transfer of Olanzapine Into Breast Milk, Calculation of Infant Drug Dose, and Effect on Breast-Fed Infants
Sharon J. Gardiner, M.Clin.Pharm.; Judith H. Kristensen, B.Pharm.; Evan J. Begg, M.D.; L. Peter Hackett, M.R.S.C.; Debbie A. Wilson, F.R.A.N.Z.C.P.; Kenneth F. Ilett, Ph.D.; Rolland Kohan, M.B.B.S.; Jonathan Rampono, F.R.A.N.Z.C.P.
The American Journal of Psychiatry. 2003 August ; 8(160):1428-1431
PDFPDF
Reviews and Overviews | July 01, 2003
Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled Trials
Stefan Leucht, M.D.; Thomas R.E. Barnes, M.D.; Werner Kissling, M.D.; Rolf R. Engel, Ph.D.; Christoph Correll, M.D.; John M. Kane, M.D.
The American Journal of Psychiatry. 2003 July ; 7(160):1209-1222
PDFPDF
Article | July 01, 2003
Olanzapine Versus Divalproex Sodium for the Treatment of Acute Mania and Maintenance of Remission: A 47-Week Study
Mauricio Tohen, M.D., Dr.P.H.; Terence A. Ketter, M.D.; Carlos A. Zarate, M.D.; Trisha Suppes, M.D., Ph.D.; Mark Frye, M.D.; Lori Altshuler, M.D.; John Zajecka, M.D.; Leslie M. Schuh, Ph.D.; Richard C. Risser, M.Sc.; Eileen Brown, Ph.D.; Robert W. Baker, M.D.
The American Journal of Psychiatry. 2003 July ; 7(160):1263-1271
PDFPDF
Article | June 01, 2003
Effects of Alcohol Dependence Comorbidity and Antipsychotic Medication on Volumes of the Thalamus and Pons in Schizophrenia
Edith V. Sullivan, Ph.D.; Margaret J. Rosenbloom, M.A.; Kathleen L. Serventi, B.S.; Anjali Deshmukh, M.D.; Adolf Pfefferbaum, M.D.
The American Journal of Psychiatry. 2003 June ; 6(160):1110-1116
PDFPDF
Article | June 01, 2003
Efficacy of the Branched-Chain Amino Acids in the Treatment of Tardive Dyskinesia in Men
Mary Ann Richardson, Ph.D.; Margaret L. Bevans, R.N.; Laura L. Read, Ph.D.; Helen M. Chao, Ph.D.; James D. Clelland, Ph.D.; Raymond F. Suckow, Ph.D.; Timothy J. Maher, Ph.D.; Leslie Citrome, M.D., M.P.H.
The American Journal of Psychiatry. 2003 June ; 6(160):1117-1124
PDFPDF
Article | June 01, 2003
Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic
John M. Kane, M.D.; Mariëlle Eerdekens, M.D., M.B.A.; Jean-Pierre Lindenmayer, M.D.; Samuel J. Keith, M.D.; Michael Lesem, M.D.; Keith Karcher, M.S.
The American Journal of Psychiatry. 2003 June ; 6(160):1125-1132
PDFPDF
Article | June 01, 2003
Effect Size of Symptom Status in Withdrawal of Typical Antipsychotics and Subsequent Clozapine Treatment in Patients With Treatment-Resistant Schizophrenia
David Pickar, M.D.; John J. Bartko, Ph.D.
The American Journal of Psychiatry. 2003 June ; 6(160):1133-1138
PDFPDF
Article | April 01, 2003
Ziprasidone in the Treatment of Acute Bipolar Mania: A Three-Week, Placebo-Controlled, Double-Blind, Randomized Trial
Paul E. Keck, Jr., M.D.; Marcio Versiani, M.D.; Steven Potkin, M.D.; Scott A. West, M.D.; Earl Giller, M.D., Ph.D.; Kathleen Ice, Ph.D.
The American Journal of Psychiatry. 2003 April ; 4(160):741-748
PDFPDF
Article | February 01, 2003
Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics
Jean-Pierre Lindenmayer, M.D.; Pal Czobor, Ph.D.; Jan Volavka, M.D., Ph.D.; Leslie Citrome, M.D., M.P.H.; Brian Sheitman, M.D.; Joseph P. McEvoy, M.D.; Thomas B. Cooper, M.A.; Miranda Chakos, M.D.; Jeffrey A. Lieberman, M.D.
The American Journal of Psychiatry. 2003 February ; 2(160):290-296
PDFPDF
Article | February 01, 2003
Attenuation of Olanzapine-Induced Weight Gain With Reboxetine in Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study
Michael Poyurovsky, M.D.; Ilanit Isaacs, M.D.; Camil Fuchs, Ph.D.; Michael Schneidman, M.D.; Sarit Faragian, M.A.; Ronit Weizman, M.D.; Abraham Weizman, M.D.
The American Journal of Psychiatry. 2003 February ; 2(160):297-302
PDFPDF
Article | February 01, 2003
Subjective Experience and D2 Receptor Occupancy in Patients With Recent-Onset Schizophrenia Treated With Low-Dose Olanzapine or Haloperidol: A Randomized, Double-Blind Study
Lieuwe de Haan, M.D., Ph.D.; Marion van Bruggen, M.D.; Jules Lavalaye, M.D., Ph.D.; Jan Booij, M.D., Ph.D.; Peter M.A.J. Dingemans, Ph.D.; Don Linszen, M.D., Ph.D.
The American Journal of Psychiatry. 2003 February ; 2(160):303-309
PDFPDF
Article | February 01, 2003
Use of System-Wide Outcomes Monitoring Data to Compare the Effectiveness of Atypical Neuroleptic Medications
Michael J. Sernyak, M.D.; Douglas Leslie, Ph.D.; Robert Rosenheck, M.D.
The American Journal of Psychiatry. 2003 February ; 2(160):310-315
PDFPDF
Copyright ©
American
Psychiatric
Association